VANGUARD GROUP INC 13D and 13G filings for Anavex Life Sciences Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Anavex Life Sciences Corp. AVXL | VANGUARD GROUP INC | 4,360,648 5.310% | 216,148 (+5.22%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Anavex Life Sciences Corp. AVXL | VANGUARD GROUP INC | 4,144,500 5.320% | 302,930 (+7.89%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Anavex Life Sciences Corp. AVXL | VANGUARD GROUP INC | 3,841,570 5.050% | 3,841,570 (New Position) | Filing |